Executive Vice President, Worldwide Chairman, MedTech · JOHNSON & JOHNSON (JNJ)

Ashley McEvoy

A named executive officer of JOHNSON & JOHNSON in every fiscal year CompBrief holds from FY2022 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$9,403,150

Salary $1,059,231Stock awards $4,015,750

FY2022: $7,390,161

5th of 6 named executive officers at Johnson & Johnson by FY2023 total.

6 named officers on file for JOHNSON & JOHNSON, FY2023

Ashley McEvoy’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 9 equity grants, each cited to its filing
  • JNJ’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how JOHNSON & JOHNSON’s whole pay program stands against its peers

  • JOHNSON & JOHNSON’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on JNJ→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 13, 2024 (DEF 14A).

Free

Get Ashley McEvoy’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Ashley McEvoy compensation by year

JOHNSON & JOHNSON Summary Compensation Table · all 2 fiscal years held
In US dollars, as JOHNSON & JOHNSON reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022FY2023
Salary$984,615$1,059,231
Bonus$0—
Stock awards$3,935,021$4,015,750
Option awards$1,535,967$1,707,004
Non-equity incentive$890,250$1,261,500
Pension and deferred compensation$0$1,312,000
All other$44,308$47,665
Total$7,390,161$9,403,150

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: JOHNSON & JOHNSON DEF 14A filed March 13, 2024, accession 0000200406-24-000024, and prior-year filings. Open the filing on EDGAR.

How this page was built: the JOHNSON & JOHNSON filed document, accession 0000200406-24-000024. Every figure is read from that document and cited to the page and table it appears in. Filed March 13, 2024.

$7.4M
$9.4M
FY22
FY23
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU21,980$3,445,145—
PSU18,083$2,834,329—
PSU13,639$2,137,777—
RSU3,704$580,565—
RSU3,347$524,609—
RSU3,136$491,537—
Option68,894—$164.62
Option66,110—$165.89
Option61,295—$162.75

Per the Outstanding Equity Awards at Fiscal Year-End table in JOHNSON & JOHNSON's FY2023 proxy; value at the fiscal year-end close, as the company printed it.

JOHNSON & JOHNSON’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Joaquin DuatoChairman & Chief Executive Officer$28,397,240
John ReedEVP, Innovative Medicine, R&D$20,647,350
Joseph WolkExecutive Vice President, Chief Financial Officer$13,914,853
Jennifer TaubertEVP, WWC Innovative Medicine$10,995,394
Ashley McEvoy · this pageExecutive Vice President, Worldwide Chairman, MedTech$9,403,150
Peter FasoloExecutive Vice President, Chief Human Resources Officer$7,502,047

The full JOHNSON & JOHNSON compensation record

free company brief

This page is one person within JOHNSON & JOHNSON's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the JOHNSON & JOHNSON proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are JOHNSON & JOHNSON's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Ashley McEvoy's compensation dossier · One-time report. No refunds.